Actavis is one of the world's leading companies specializing in the development, manufacture and sale of generic pharmaceuticals. Actavis has operations in more than 40 countries, with 11,000 employees.

In 2011, Actavis had estimated sales of EUR 1.8bn, with approximately one-third of these sales coming from the United States, the Company's single largest market. Actavis had over 700 product and market launches in 2011.